PT  - JOURNAL ARTICLE
AU  - Mathew Mbwogge
TI  - Mass Testing with Contact Tracing Compared to Test and Trace for Effective Suppression of COVID-19 in the UK: A rapid review
AID  - 10.1101/2021.01.13.21249749
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.13.21249749
4099  - http://medrxiv.org/content/early/2021/01/15/2021.01.13.21249749.short
4100  - http://medrxiv.org/content/early/2021/01/15/2021.01.13.21249749.full
AB  - Background Making testing available to everyone and tracing contacts might be the gold standard towards the control of COVID-19, particularly when significant transmissions are without symptoms. This study evaluated the effectiveness of mass testing and contact tracing in the suppression of COVID-19 compared to conventional Test and Trace in the UK.Design A rapid review of available evidencePrimary research question Is there evidence that mass testing and tracing could suppress community spread of SARS-CoV-2 infections better than Test and Trace?Secondary research question What is the proportion of asymptomatic cases of SARS-CoV-2 reported during mass testing interventions?Methods Literature was searched in September through December 2020 in Google Scholar, ScienceDirect, Mendeley and PubMed.Results Literature search yielded 286 articles from Google Scholar, 20 from Science Direct, 14 from Mendeley, 27 from Pubmed and 15 through manual search. Altogether 35 articles were included, making a sample size of close to a million participants.Conclusion There was a very low level but promising evidence of 76.9% (95% CI: 46.2 – 95.0, P=0.09) majority vote in favour of the intervention under the primary objective. The overall proportion of asymptomatic cases among those tested positive and tested sample populations under the secondary objective was 40.7% (95% CI: 38.8– 42.5) and 0.01% (95% CI: 0.01 – 0.012) respectively. Conventional test and trace should be superseded by a decentralised and regular mass rapid testing and contact tracing, championed by GP surgeries and low cost community services.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was recieved for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere is no additional data